Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex

Annals of Tropical Medicine and Parasitology

Volumn 92, Issue 7, 1998, Pages 755-764

  Sundar, S ^a   Goyal, A K ^a   More, D K ^a   Singh, M K ^a   Murray, H W ^b  

^a BANARAS HINDU UNIVERSITY   (India)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIMONY; ANTIPROTOZOAL AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; FEMALE; FEVER; HEALTH CARE COST; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; VISCERAL LEISHMANIASIS;

NASO HEXACANTHUS; PROTOZOA;

EID: 0032322677     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1080/00034983.1998.11813337     Document Type: Article

References (31)

1. BADARO, R., FALCOFF, E., BADARO, F. S., CARVALHO, E. M., PEDRAL-SAMPAIO, D., BARRAL, A., CARVALHO, J. S., BARRAL-NETTO, M., BRANDELY, M., SILVA, L., BINHA, J. C., TEIXEIRA, R., FALCOFF, R., ROCHA, H., HO, J. L. & JOHNSON, W. D. (1990). Treatment of visceral leishmaniasis with pentavalent antimony and interferon-gamma. New England Journal of Medicine, 322, 16-21.
2. BERMAN, J. D. (1997). Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clinical Infectious Diseases, 24, 684-703.
3. CHUNGE, C. N., OWATE, J., PAMBA, H. O. & DONNO, L. (1990). Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 221-225.
4. DAVIDSON, R. N., DI MARTINO, L., GRADONI, L., GIACCHINO, R., RUSSO, R., GAETA, G. B., PEMPINELLO, R., SCOTT, S., RAIMONDI, F., CASCIO, A., PRESTILEO, T., CALDEIRA, L., WILKINSON, R. J. & BRYCESON, A. D. M. (1994). Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial. Quarterly Journal of Medicine, 87, 75-81.
5. DAVIDSON, R. N., DI MARTINO, L., GRADONI, L., GIACCIHNO, R., GAETA, G. B., PEMPINELLO, R., SCOTTI, S., CASCIO, A., CASTAGNOLA, E., MAISTO, A., GRAMICCIA, M., DI CAPRIO, D., WILKINSON, R. J. & BRYCESON, A. D. M. (1996). Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome). Clinical Infectious Diseases, 22, 938-943.
6. DIETZE, R., FAGUNDES, S. M. S., BRITO, E. F., MILAN, E. P., FEITOSA, T. F., SUASSUNA, F. A. B., FONSCHIFFREY, G., KSIONSKI, G. & DEMBER, J. (1995). Treatment of kala-azar in Brazil with Amphocil (amphotericin B cholesterol dispersion) for 5 days. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 309-311.
7. GIRI, O. P. (1994). Treatment of visceral leishmaniasis unresponsive to pentamidine with amphotericin B. Journal of the Association of Physicians of India, 42, 688-689.
8. GRADONI, L., BRYCESON, A. & DESJEUX, P. (1995). Treatment of Mediterranean visceral leishmaniasis. Bulletin of the World Health Organization, 73, 191-197.
9. JHA, S. N., SINGH, N. K. P. & JHA, T. K. (1991). Changing response to diamidine compounds in cases of kala-azar unresponsive to antimonial. Journal of the Association of Physicians of India, 39, 314-316.
10. JHA, T. K., GIRI, Y. N., SINGH, T. K. & JHA, S. (1995). Use of amphotericin B in drug-resistant cases of visceral leishmaniasis in north Bihar, India. American Journal of Tropical Medicine and Hygiene, 52, 536-538.
11. JHA, T. K., OLLIARO, P., THAKUR, C. P., KANYOK, T. P., SINGHANIA, B. L., SINGH, I. J., SINGH, N. K. P., AKHOURY, S. & JHA, S. (1998). Randomized controlled trial of aminosidine (paramomycin) v. sodium stibogluconate for treating visceral leishmaniasis in north Bihar, India. British Medical Journal, ii, 1200-1205.
12. MISHRA, M., BISWAS, U. K., JHA, D. N. & KHAN, A. B. (1992). Amphotericin B versus pentamidine in antimony-unresponsive kala-azar. Lancet, ii, 1256-1257.
13. MISHRA, M., BISWAS, U. K., JHA, A. M. & KHAN, A. B. (1994). Amphotericin B versus sodium stibogluconate in first-line treatment of Indian kala-azar. Lancet, ii, 1599-1600.
14. MURRAY, H. W., HARIPRASHAD, J. & FICHTL, R. (1996). Models of relapse of experimental visceral leishmaniasis. Journal of Infectious Diseases, 173, 1041-1043.
15. PEARSON, R. D. & DE QUEIROZ SOUZA, A. (1996). Clinical spectrum of leishmaniasis. Clinical Infectious Diseases, 22, 1-13.
16. RIBERA, E., OCANA, I., DE OTERO, J., CORTES, E., GASSER, I. & PAHISSA, A. (1996). Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients. American Journal of Medicine, 100, 496-501.
17. RUSSO, R., NIGRO, L. C., MINNITI, S., MONTINERI, A., GRADONI, L., CALDEIRA, L. & DAVIDSON, R. N. (1996). Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome). Journal of Infection, 32, 133-137.
18. SEAMAN, J., BOER, C., WILKINSON, R., DE JONG, J., DE WILDE, E., SONDORP, E. & DAVIDSON, R. (1995). Liposomal amphotericin B (AmBisome) in the treatment of complicated kala-azar under field conditions. Clinical Infectious Diseases, 21, 188-193.
19. SUNDAR, S. (1996). Treatment of kala-azar. In Indian Kala-azar, ed. Sundar, S. pp. 67-84. Varanasi, India: M. Khandelwal Offsets.
20. SUNDAR, S. & MURRAY, H. W. (1996). Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex. Journal of Infectious Diseases, 173, 762-765.
21. SUNDAR, S. & MURRAY, H. W. (1998). Costs of amphotericin B lipid complex for kala-azar (letter). Annals of Internal Medicine, 128, 326.
22. SUNDAR, S., ROSENKAIMER, F. & MURRAY, H. W. (1994). Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-γ. Journal of Infectious Diseases, 170, 659-663.
23. SUNDAR, S., AGRAWAL, N. K., SINHA, P. R., HORWITH, G. S. & MURRAY, H. W. (1997a). Short-course, low dose amphotericin 15 lipid complex therapy for visceral leishmaniasis unresponsive to antimony. Annals of Internal Medicine, 127, 133-137.
24. SUNDAR, S., SINGH, V. P., SHARMA, S., MAKHARIA, M. K. & MURRAY, H. W. (1997b). Response to interferon-γ plus pentavalent antimony in Indian visceral leishmaniasis. Journal of Infections Diseases, 176, 1117-1119.
25. SUNDAR, S., GOYAL, A. K., MANDAL, A. K., MAKHARIA, M. K., SINGH, V. P. & MURRAY, H. W. (1998). Amphotericin B lipid complex in the management of antimony unresponsive Indian visceral leishmaniasis. Journal of the Association of Physicians of India, in press.
26. THAKUR, C. P., KUMAR, M., KUMAR, P., MISHRA, B. N. & PANDEY, A. K. (1988). Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomized study. British Medical Journal, ii, 1557-1561.
27. THAKUR, C. P., KUMAR, M. & PANDEY, A. K. (1991a). Evaluation of efficacy of longer durations of therapy of fresh cases of kala-azar with sodium stibogluconate. Indian Journal of Medical Research, 93, 103-110.
28. THAKUR, C. P., KUMAR, M. & PANDEY, A. K. (1991b). Comparison of regimes of treatment of antimony-resistant kala-azar patients: a randomized study. American Journal of Tropical Medicine and Hygiene, 45, 435-441.
29. THAKUR, C. P., SINHA, G. P., PANDEY, A. K., BARAT, D. & SINHA, P. K. (1993). Amphotericin B in resistant kala-azar in Bihar. National Medical Journal of India, 6, 57-60.
30. THAKUR, C. P., SINHA, G. P., BARAT, D. & SINGH, R. K. (1994). Are incremental doses of amphotericin B required for the treatment of visceral leishmaniasis? Annals of Tropical Medicine and Parasitology, 88, 365-370.
31. THAKUR, C. P., PANDEY, A. K., SINHA, G. P., ROY, S., BEHBEHANI, K. & OLLIARO, P. (1996). Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 319-322.